Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03359850 |
| Title | Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Los Angeles | California | 90033 | United States | Details | |
| GSK Investigational Site | Newport Beach | California | 92663 | United States | Details | |
| GSK Investigational Site | Aurora | Colorado | 80045 | United States | Details | |
| GSK Investigational Site | Atlanta | Georgia | 30322 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details |